Clinical Trial Update: Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA

View source ↗

Summary

An AbbVie-sponsored real-life study evaluating Humira (adalimumab) in Israeli rheumatoid arthritis patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Status: WITHDRAWN